These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11165673)

  • 41. Consensus guidelines for high dose rate remote brachytherapy in cervical, endometrial, and endobronchial tumors. Clinical Research Committee, American Endocurietherapy Society.
    Nag S; Abitbol AA; Anderson LL; Blasko JC; Flores A; Harrison LB; Hilaris BS; Martinez AA; Mehta MP; Nori D
    Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1241-4. PubMed ID: 8262853
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High-dose-rate brachytherapy for carcinoma of the cervix: high tech or high risk?
    Eifel PJ
    Int J Radiat Oncol Biol Phys; 1992; 24(2):383-6; discussion 387-8. PubMed ID: 1526879
    [No Abstract]   [Full Text] [Related]  

  • 43. Effect of bladder distention on bladder base dose in gynaecological intracavitary high dose rate brachytherapy.
    Adli M; Garipagaoglu M; Kocak Z
    Br J Radiol; 2009 Mar; 82(975):243-8. PubMed ID: 19064593
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High-dose-rate intracavitary brachytherapy for gynecologic malignancies.
    Stitt JA
    Oncology (Williston Park); 1992 Jan; 6(1):59-70, 79; discussion 80-2. PubMed ID: 1531604
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prediction of severe late complications in fractionated, high dose-rate brachytherapy in gynecological applications.
    Van Lancker M; Storme G
    Int J Radiat Oncol Biol Phys; 1991 May; 20(5):1125-9. PubMed ID: 2022515
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Magnetic Resonance Imaging-Guided High-Dose Rate Brachytherapy for Cervical Cancer.
    Meier T; Kharofa J
    Semin Roentgenol; 2016 Apr; 51(2):106-11. PubMed ID: 27105965
    [No Abstract]   [Full Text] [Related]  

  • 47. Fractionation is important for HDR cervix cancer brachytherapy.
    Orton CG
    Int J Radiat Oncol Biol Phys; 1992; 22(1):222-3. PubMed ID: 1727122
    [No Abstract]   [Full Text] [Related]  

  • 48. Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer.
    Tanderup K; Fokdal LU; Sturdza A; Haie-Meder C; Mazeron R; van Limbergen E; Jürgenliemk-Schulz I; Petric P; Hoskin P; Dörr W; Bentzen SM; Kirisits C; Lindegaard JC; Pötter R
    Radiother Oncol; 2016 Sep; 120(3):441-446. PubMed ID: 27350396
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Australian high-dose-rate brachytherapy protocols for gynaecological malignancy.
    MacLeod C; Cheuk R; Dally M; Fowler A; Gauden S; Leung S; Milross C; Narayan K; Stevens M; Thornton D; Carruthers S; Jeal P
    Australas Radiol; 2001 Feb; 45(1):43-8. PubMed ID: 11259972
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of dosimetric parameters on local control for patients treated with three-dimensional pulsed dose-rate brachytherapy for cervical cancer.
    Boyrie S; Charra-Brunaud C; Harter V; Ducassou A; Kirova Y; Barillot I; Krzisch C; Lang P; Baron MH; Montbarbon X; Delannes M; Peiffert D
    Brachytherapy; 2014; 13(4):326-31. PubMed ID: 24946972
    [TBL] [Abstract][Full Text] [Related]  

  • 51. One versus two or more brachytherapy applications in cervical cancer.
    Smit BJ
    Int J Radiat Oncol Biol Phys; 1992; 23(2):477. PubMed ID: 1587773
    [No Abstract]   [Full Text] [Related]  

  • 52. A Multi-institution, Retrospective Analysis of Cervix Intracavitary Brachytherapy Treatments. Part 1: Is EQD2 Good Enough for Reporting Radiobiological Effects?
    Fields EC; Melvani R; Hajdok G; D'Souza D; Jones B; Stuhr K; Diot Q; Fisher CM; Mukhopadhyay N; Todor D
    Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):219-226. PubMed ID: 28816149
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dose-volume histogram analysis of high dose rate intracavitary brachytherapy for uterine cervix cancer.
    Terahara A; Nakano T; Ishikawa A; Morita S; Tsuji H
    Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):549-54. PubMed ID: 8655379
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
    Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
    Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Variability of a dose in external irradiation by a split field].
    Tacev T; Krystof V
    Cesk Radiol; 1980 May; 34(3):186-90. PubMed ID: 6772318
    [No Abstract]   [Full Text] [Related]  

  • 56. Dosimetric analysis at ICRU reference points in HDR-brachytherapy of cervical carcinoma.
    Eich HT; Haverkamp U; Micke O; Prott FJ; Müller RP
    Rontgenpraxis; 2000; 53(2):62-6. PubMed ID: 10994367
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Radiotherapy of cervix and endometrial carcinoma].
    Barillot I; Haie-Méder C; Charra Brunaud C; Peignaux K; Kerr C; Thomas L
    Cancer Radiother; 2016 Sep; 20 Suppl():S189-95. PubMed ID: 27523423
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Individualised 3D printed vaginal template for MRI guided brachytherapy in locally advanced cervical cancer.
    Lindegaard JC; Madsen ML; Traberg A; Meisner B; Nielsen SK; Tanderup K; Spejlborg H; Fokdal LU; Nørrevang O
    Radiother Oncol; 2016 Jan; 118(1):173-5. PubMed ID: 26743833
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dosimetry and complication rate in the treatment of cervix carcinoma with external irradiation and brachytherapy.
    Kuipers T
    Sonderb Strahlenther Onkol; 1988; 82():127-31. PubMed ID: 3134708
    [No Abstract]   [Full Text] [Related]  

  • 60. High-risk CTV delineation for cervix brachytherapy: Application of GEC-ESTRO guidelines in Australia and New Zealand.
    Vinod SK; Lim K; Bell L; Veera J; Ohanessian L; Juresic E; Borok N; Chan P; Chee R; Do V; Govindarajulu G; Sridharan S; Johnson C; Moses D; Van Dyk S; Holloway L
    J Med Imaging Radiat Oncol; 2017 Feb; 61(1):133-140. PubMed ID: 27527506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.